DOI: http://dx.doi.org/10.18203/2349-3933.ijam20175184

Comparison of dexmedetomidine and buprenorphine as an adjuvant to bupivacaine during spinal anaesthesia for tibial interlocking nailing surgeries

Amitha S., Pradeep R.

Abstract


Background: Buprenorphine is being used as an adjuvant to local anaesthetic for spinal anaesthesia since long. Dexmedetomidine is a new drug which has got alpha 2 agonistic property, and is being tried for spinal anesthesia along with bupivacaine in recent times. Settings and Design: This study was conducted in a prospective, randomized, controlled and double-blind manner. The study included ninety American Society of Anaesthesiologists class I and II patients undergoing tibial interlocking nailing surgeries under spinal anaesthesia.

Methods: The patients were randomly divided into three groups (n=30 each) by closed envelope technique. Patients in group 1 received 15 mg of 0.5% hyperbaric bupivacaine, group 2 received 15 mg of 0.5% hyperbaric bupivacaine with 30μg of buprenorphine, and group 3 received 15 mg of 0.5% hyperbaric bupivacaine with 5μg dexmedetomidine for spinal anesthesia. The duration of motor and sensory blockade and any adverse events were recorded. Data were analysed using Chi-square test or Fisher’s exact test for categorical data and analysis of variance for continuous data. A value of P<0.05 was considered as statistically significant.

Results: In our study the subjects in group 3 (dexmedetomidine) group had significantly longer period of motor blockade (240±20min) and sensory blockade (180±22.2min) compared to other groups, which is statistically significant (P=0.0001 and P= 0.006 respectively). The time to first request of analgesic in the post-operative period was also longer (240±30.2min) in dexmedetomidine group when compared with other groups (P=0.0001). There were no untoward complications (hypotension, sedation) in any groups.

Conclusions: We concluded that dexmedetomidine (5μg) with bupivacaine for spinal anesthesia gives significantly longer duration of sensory and motor blockade, than buprenorphine (30μg) with bupivacaine for spinal anaesthesia.


Keywords


α2-adrenoreceptor agonist, Bupivacaine, Buprenorphine

Full Text:

PDF

References


Mahendru V, Tewari A, Katyal S, Grewal A, Singh MR, Katyal R. A comparison of intrath-ecal dexmedetomidine, clonidine, and fentanyl as adjuvants to hyperbaric bupivacaine for lower limb surgery: A double blind controlled study. J Anaesthesiol Clin Pharmacol. 2013;29(4):496-502.

Gupta M, Shailaja S, Hegde KS. Comparison of intrathecal dexmedetomidine with bu-prenorphine as adjuvant to bupivacaine in spinal anaesthesia. J Clin Diagn Res. 2014;8(2):114-7.

Abdelhamid SA, El-lakany MH (2013) Intrathecal dexmedetomidine: Useful or not? J Anesth Clin Res. 2013;4:351.

Gupta R, Verma R, Bogra J, Kohli M, Raman R, Kushwaha JK. A Comparative study of intrathecal dexmedetomidine and fentanyl as adjuvants to Bupivacaine. J Anaesthesiol Clin Pharmacol. 2011; 27(3):33943.

Eidhea, Shafie MA, Youssef H. Dose-related prolongation of hyperbaric bupivacaine Spinal anesthesia by dexmedetomidine. Ain Shams J Anesthesiol. 2011;4:83-95.

Kanazi GE, Aouad MT, Jabbour-Khoury SI, Jazzar AL, Alameddine MM, Al-Yaman R, et al. Effect of low-dose dexmedetomidine or clonidine on the characteristics of bupivacaine spinal block. Acta Anaesthesiol Scand. 2006;50(2):222-7.

Kalso E, Poyhia R, Rosenberg P. Spinal anti-nociception by dexmedetomidine, a highly selective a2-adrenergic agonist. Pharmacol Toxicol. 1991; 68(2):140-3.

Asano T, Dohi S, Ohta S, Shimonaka H, Lida H. Anti-nociception by epidural and systemic alpha 2 adrenoreceptor agonists and their binding affinity in rat spinal cord and brain. Anesth Analg. 2000; 90(2):400-7.

Shah A, Patel I, Gandhi R. Haemodynamic effects of intrathecal dexmedetomidine added to ropivacaine intraoperatively and for postoperative analgesia. Int J Basic Clin. 2013;2:26-9.

Eisenach JC, De Kock M, Klimscha W. Alpha (2)-adrenergic agonists for regional anes-thesia. A clinical review of clonidine (1984-1995). Anesthesiol.1996;85(3):655-74.

Bromage PR. A comparison of the hydrochloride and carbon dioxide salts of lidocaine and prilocaine in epidural analgesia. Acta Anaesthesiologica Scandinavica. 1965;9:55-69.

Graham AC, McClue JH. Quantitative assessment of motor block in laboring women re-ceiving epidural analgesia. Anaesthes. 2001;56:470-6.

Ramsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxolone-alphadalone. Br Med J. 1974;2(5920):656-9.

Wewers ME, Lowe NK. A critical review of visual analogue scales in the measurement of clinical phenomena. Research in Nursing and Health. 1990; 13:227-36.

Kim JE, Kim NY, Lee HS, Kil HK. Effects of intrathecal dexmedetomidine on low-dose bu-pivacaine spinal anesthesia in elderly patients undergoing transurethral prostatectomy. Biol Pharm Bull. 2013;36(6):959-65.

Singh R, Shukla. A randomized, controlled study to compare the effect of intrathecal clonidine and dexmedetomidine on sensory analgesia and motor block of hyperbaric bupivacaine. JLS. 2012;2(4): 24-33.

Niu XY, Ding XB, Guo T, Chen MH, Fu SK, Li Q. Effects of intravenous and Intrathecal dex-medetomidine in spinal anesthesia: a meta-analysis. CNS Neurosci Ther. 2013;19(11):897-904.

Bulow NM, Barbosa NV, Rocha JB. Opioid consumption in total intravenous anesthesia is reduced with dexmedetomidine: a comparative study with remifentanil in gynecologic video laparoscopic surgery. J Clin Anesth. 2007;19(4): 280-5.

Ding Z, Raffa RB. Identification of an additional supraspinal component to the analgesic mechanism of action of buprenorphine. Br J Pharmacol. 2009; 157:831-43.

Leffler A, Frank G, Kishner K, Niedermirtl F, Koppert W, Reeh PW, et al. Local anesthet-ic-like inhibition of voltage-gated Na(+) channels by the partial μ-opioid receptor agonist buprenorphine. Anesthesiol. 2012;116:1335-46.